Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christine Ann Andrews is active.

Publication


Featured researches published by Christine Ann Andrews.


ChemBioChem | 2008

Self-Cleavable Bioluminogenic Luciferin Phosphates as Alkaline Phosphatase Reporters

Wenhui Zhou; Christine Ann Andrews; Jianquan Liu; John Shultz; Michael P. Valley; Jim Cali; Erika Hawkins; Dieter Klaubert; Robert F. Bulleit; Keith V. Wood

Alkaline phosphatase (AP)—a stable enzyme with high specific activity for the hydrolysis of phosphate esters—is widely used as a conjugated enzyme label in enzyme-linked immunosorbent assays (ELISA) and DNA hybridization assays. It is also used as an in situ probe to monitor the expression and translocation of fusion proteins from the cytoplasm and for visualization of the spatial distribution of target biomolecules, such as cognate ligands or receptors in cells, tissues, and embryos. Among the many methods for detecting AP activity, there are various phosphate substrates, such as the colorimetric p-nitrophenyl phosphate, the fluorescent AttoPhos<, and the chemiluminescent adamantyl 1,2-diACHTUNGTRENNUNGoxetane AMPPD derivatives (Scheme 1). It is the ultrasensitivity of chemiluminescence, specifically with 1,2-dioxetane AMPPD derivatives, that has made this the overwhelming choice for monitoring AP activity. Although a luciferase-coupled bioluminescent assay is not only generically similar to the chemiluminescent assay and could show similar sensitivity, it also has the additional potential of creating recombinant luciferase to AP protein fusions, which might be preferable for the detection of AP activity in situ. The development of a suitable substrate to reach this ultrasensitivity is needed in order to promote the bioluminescent AP assay for practical applications. Chemical modification of the 6-hydroxyl group of luciferin (or the 6-amino group of aminoluciferin) is an effective means to approach bioluminescent assays for enzymes of interest, and 6-luciferin phosphate (Scheme 1) has been previously shown to detect AP activity. However, the detection limit of 10 19 mol of AP was 2–3 orders of magnitude lower than that for the AMPPD assay. Since the hydrolysis of phosphate monoesters is highly dependent on the pKa of the leaving group and the lower pKa 8.5 [11] of the luciferin phenol compared to a pKa ~9.0 of the adamantyl dioxetane phenol favors both nucleophilic attack and P O bond fission Scheme 1. Chemical structures of substrates for AP enzyme. A) Known chemiluminescent substrate AMPPD derivatives and bioluminescent substrate 6-luciferin phosphate; B) proposed self-cleavable luciferin phosphates, aminoluciferin trimethyl lock phosphate 1, and luciferin p-hydroxymethylphenyl phosphate 2.


Archive | 1999

Nucleic acid detection

John Shultz; Martin K. Lewis; Donna Leippe; Michelle Mandrekar; Daniel Kephart; Richard Byron Rhodes; Christine Ann Andrews; James Robert Hartnett; Trent Gu; Ryan J. Olson; Roy D. Welch


Archive | 2001

Detection of nucleic acid hybrids

John Shultz; Martin K. Lewis; Donna Leippe; Michelle Mandrekar; Daniel Kephart; Richard Byron Rhodes; Christine Ann Andrews; James Robert Hartnett; Trent Gu; Ryan J. Olson; Keith V. Wood; Roy D. Welch


Archive | 2001

Multiplex method for nucleic acid detection

Martin K. Lewis; Daniel Kephart; Richard Byron Rhodes; John Shultz; Donna Leippe; Michelle Mandrekar; Christine Ann Andrews; James Robert Hartnett; Trent Gu; Keith V. Wood; Roy D. Welch


Archive | 2001

Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection

John Shultz; Ryan J. Olson; Christine Ann Andrews


Archive | 1999

Deploymerization method for nucleic acid detection of an amplified nucleic acid target

John Shultz; Martin K. Lewis; Donna Leippe; Michelle Mandrekar; Christine Ann Andrews; James Robert Hartnett; Roy D. Welch


Archive | 1999

Exogenous nucleic acid detection

John Shultz; Martin K. Lewis; Donna Leippe; Michelle Mandrekar; Daniel Kephart; Richard Byron Rhodes; Christine Ann Andrews; James Robert Hartnett; Trent Gu; Ryan J. Olson; Keith V. Wood; Roy D. Welch


BioTechniques | 1998

Selection strategy for site-directed mutagenesis based on altered β-lactamase specificity

Christine Ann Andrews; Scott A. Lesley


Archive | 2000

Methods for determining the presence of nucleic acid target sequences and applications thereof

John Shultz; Martin K. Lewis; Donna Leippe; Michelle Mandrekar; Daniel Kephart; Richard Byron Rhodes; Christine Ann Andrews; James Robert Hartnett; Trent Gu; Ryan J. Olson; Keith V. Wood; Roy D. Welch


Archive | 2004

Method of inactivating ribonucleases at high temperature

Fen Huang; Christine Ann Andrews; John Shultz

Collaboration


Dive into the Christine Ann Andrews's collaboration.

Researchain Logo
Decentralizing Knowledge